Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Sleep Res. 2013 Sep 2;23(1):69–76. doi: 10.1111/jsr.12086

Table 3.

Significance (p-value)* for multivariable associations of quality of life outcomes with OSA Risk, Demographics, and Comorbidities; and univariate parameter estimates from demographic and comorbidity model for significant (p < 0.05) associations.

Multivariable Unadjusted p-value n=2925 Multivariable Demographics Adjusted p-value n=2925 Multivariable Demographics and Comorbidity Adjusted p-value n=2799 Univariate Parameter Estimates for Significant Predictors** (Demographics and Comorbidity Adjusted Model)
CES-D-4 PCS MCS
OSA risk (high vs. low) <.0001 <.0001 <.0001 2.42 -15.1 -6.32
Age at BSQ completion (per 1 year increment) <.0001 <.0001 <.0001 -0.003 -0.04 0.12
Gender (men vs. women) <.0001 <.0001 <.0001 -0.33 2.30 1.39
Education (college grad vs. less than high school) <.0001 <.0001 <.0001 -0.99 5.49 2.85
Race (black vs. white) <.0001 0.1958 0.6869 n.s. n.s. n.s.
Diabetes (yes vs. no) <.0001 -- <.0001 0.34 -4.15 -0.91
Dyslipidemia (yes vs. no) <.0001 -- 0.005 -1.34 n.s.
Age × OSA risk interaction -- 0.0002 0.0002 -0.03 0.19 n.s.
*

Cells contain p-values of Wilks’ Lambda tests derived from MANOVA unadjusted model and MANCOVA adjusted models.

**

CES-D-4 (4-item Center for Epidemiological Studies-Depression Scale) depressive symptoms, SF-12 PCS (Medical Outcomes Study Short Form-12: Physical Component Summary), and SF-12 MCS (Medical Outcomes Study Short Form-12: Mental Component Summary).